MMS is a quality-focused, global clinical research organization (CRO) that supports leading pharmaceutical and biotech companies as well as many smaller enterprises across our spectrum of services. Having completed more than 50 submissions for drug approval over the last five years, we remain a top choice for sponsors who are looking for innovation and demand high quality from their CRO partners.
Senior leadership at MMS has more than two decades of hands-on drug development experience, which helps support program-level strategy and execution of projects across multiple therapeutic areas. Continual staff training, innovative recruitment, and motivating career opportunities help MMS retain the best talent and develop a strong, client-focused workforce across all global locations.
MMS was named Best Global Biotech Clinical Research Organization (CRO) in the 2018 International Life Sciences Awards.
Adaptive Parallel Processing™
For each project we undertake, the internal MMS team collaborates using Adaptive Parallel Processing™, a unique, trademarked system that allows flexibility, subject-matter expertise, process optimization, and risk planning for the project to ensure on-time delivery and added value to each client.